» Articles » PMID: 24100041

Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Oct 9
PMID 24100041
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Wilms' tumor 1-associating protein (WTAP) is a putative splicing regulator that is thought to be required for cell cycle progression through the stabilization of cyclin A2 mRNA and mammalian early embryo development. To further understand how WTAP acts in the context of the cellular machinery, we identified its interacting proteins in human umbilical vein endothelial cells and HeLa cells using shotgun proteomics. Here we show that WTAP forms a novel protein complex including Hakai, Virilizer homolog, KIAA0853, RBM15, the arginine/serine-rich domain-containing proteins BCLAF1 and THRAP3, and certain general splicing regulators, most of which have reported roles in post-transcriptional regulation. The depletion of these respective components of the complex resulted in reduced cell proliferation along with G2/M accumulation. Double knockdown of the serine/arginine-rich (SR)-like proteins BCLAF1 and THRAP3 by siRNA resulted in a decrease in the nuclear speckle localization of WTAP, whereas the nuclear speckles were intact. Furthermore, we found that the WTAP complex regulates alternative splicing of the WTAP pre-mRNA by promoting the production of a truncated isoform, leading to a change in WTAP protein expression. Collectively, these findings show that the WTAP complex is a novel component of the RNA processing machinery, implying an important role in both posttranscriptional control and cell cycle regulation.

Citing Articles

Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai.

Escuder-Rodriguez J, Rodriguez-Alonso A, Jove L, Quiroga M, Alfonsin G, Figueroa A Cell Mol Biol Lett. 2025; 30(1):9.

PMID: 39833727 PMC: 11749156. DOI: 10.1186/s11658-025-00693-y.


Rapid Detection of Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling.

Middlezong W, Stinnett V, Phan M, Phan B, Morsberger L, Klausner M Biomolecules. 2025; 14(12.

PMID: 39766302 PMC: 11674480. DOI: 10.3390/biom14121595.


Distinct pathways utilized by METTL3 to regulate antiviral innate immune response.

Hao H, Zhang F, Chen Z, Tan Z, Zhang H, Feng X iScience. 2025; 27(11):111071.

PMID: 39759074 PMC: 11700651. DOI: 10.1016/j.isci.2024.111071.


Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis.

Gao Y, Zhang S, Zhang X, Du Y, Ni T, Hao S iScience. 2024; 27(12):111359.

PMID: 39660050 PMC: 11629229. DOI: 10.1016/j.isci.2024.111359.


Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects.

Kaur P, Sharma P, Bhatia P, Singh M Front Oncol. 2024; 14:1445794.

PMID: 39600630 PMC: 11590065. DOI: 10.3389/fonc.2024.1445794.


References
1.
Kelley R, Wang J, Bell L, Kuroda M . Sex lethal controls dosage compensation in Drosophila by a non-splicing mechanism. Nature. 1997; 387(6629):195-9. DOI: 10.1038/387195a0. View

2.
Fukusumi Y, Naruse C, Asano M . Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo. Dev Dyn. 2008; 237(3):618-29. DOI: 10.1002/dvdy.21444. View

3.
Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K . Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol. 2006; 208(5):662-72. DOI: 10.1002/path.1928. View

4.
Valcarcel J, Singh R, Zamore P, Green M . The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature. 1993; 362(6416):171-5. DOI: 10.1038/362171a0. View

5.
Zhou Z, Licklider L, Gygi S, Reed R . Comprehensive proteomic analysis of the human spliceosome. Nature. 2002; 419(6903):182-5. DOI: 10.1038/nature01031. View